Haleon plc Share Price Nyse

Equities

HLN

US4055521003

Pharmaceuticals

Market Closed - Nyse 01:30:02 22/05/2024 am IST Pre-market 06:48:41 pm
8.52 USD +0.12% Intraday chart for Haleon plc 8.43 -1.06%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 11.45B 14.58B 1,213B Sales 2025 * 11.93B 15.19B 1,264B Capitalization 30.27B 38.55B 3,206B
Net income 2024 * 1.46B 1.86B 155B Net income 2025 * 1.69B 2.15B 179B EV / Sales 2024 * 3.33 x
Net Debt 2024 * 7.81B 9.95B 828B Net Debt 2025 * 7.07B 9B 749B EV / Sales 2025 * 3.13 x
P/E ratio 2024 *
20.7 x
P/E ratio 2025 *
18 x
Employees 25,408
Yield 2024 *
1.86%
Yield 2025 *
2.15%
Free-Float 81.7%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.06%
1 week+2.40%
Current month-0.12%
1 month+3.65%
3 months+2.28%
6 months+2.40%
Current year+3.52%
More quotes
1 week
8.26
Extreme 8.255
8.62
1 month
8.12
Extreme 8.12
8.64
Current year
7.89
Extreme 7.89
8.71
1 year
7.70
Extreme 7.695
8.96
3 years
5.59
Extreme 5.59
9.05
5 years
5.59
Extreme 5.59
9.05
10 years
5.59
Extreme 5.59
9.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 22/21/22
Director of Finance/CFO 52 01/21/01
Chief Tech/Sci/R&D Officer - 16/21/16
Members of the board TitleAgeSince
Director/Board Member - 18/22/18
Director/Board Member 64 18/22/18
Director/Board Member 57 18/22/18
More insiders
Date Price Change Volume
21/24/21 8.52 +0.12% 14,459,865
20/24/20 8.51 0.00% 10,676,525
17/24/17 8.51 +1.67% 11,451,940
16/24/16 8.37 -0.48% 13,372,317
15/24/15 8.41 +1.08% 8,872,461

Delayed Quote Nyse, May 22, 2024 at 01:30 am IST

More quotes
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.315 GBP
Average target price
3.62 GBP
Spread / Average Target
+9.20%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW